JMERC
Owner
Janbazan Medical and Engineering Research Center (JMERC) is the owner of IJWPH.
0.3
Cite Score
SJR: 0.114 / SNIP: 0.090
Volume 13, Issue 2 (2021)
Iran J War Public Health 2021, 13(2): 163-170 |
Back to browse issues page
Article Type:
Subject:
History
Received: 2021/10/6 | Accepted: 2021/10/12 | Published: 2021/11/2
Received: 2021/10/6 | Accepted: 2021/10/12 | Published: 2021/11/2
How to cite this article
Shepetko-Dombrovska O, Varbanets S, Meshkova M, Mokhnatyi S, Marushko Y, Neshva V et al . Effectiveness of Left-Sided Surgical Ablation for Patients with Atrial Fibrillation Concomitant with Cardiac Surgery. Iran J War Public Health 2021; 13 (2) :163-170
URL: http://ijwph.ir/article-1-1038-en.html
URL: http://ijwph.ir/article-1-1038-en.html
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Rights and permissions
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Authors
O. Shepetko-Dombrovska *1, S. Varbanets1, M. Meshkova2, S. Mokhnatyi3, Y. Marushko4, V. Neshva1, N. Rudenko5
1- Department of Adult Cardiac Surgery, Clinic for Adults, Scientific-Practical Medical Center for Pediatric Cardiology and Cardiac Surgery, Kyiv, Ukraine
2- Department of Electrophysiology, Clinic for Adults, Scientific-Practical Medical Center for Pediatric Cardiology and Cardiac Surgery, Kyiv, Ukraine
3- Department of Emergency Surgery, Clinic for Adults, Scientific-Practical Medical Center for Pediatric Cardiology and Cardiac Surgery, Kyiv, Ukraine
4- Department of Interventional Cardiology, Clinic for Adults, Scientific-Practical Medical Center for Pediatric Cardiology and Cardiac Surgery, Kyiv, Ukraine
5- Department of Pediatric Cardiology and Cardiac Surgery, Clinic for Adults, Scientific-Practical Medical Center for Pediatric Cardiology and Cardiac Surgery, Kyiv, Ukraine
2- Department of Electrophysiology, Clinic for Adults, Scientific-Practical Medical Center for Pediatric Cardiology and Cardiac Surgery, Kyiv, Ukraine
3- Department of Emergency Surgery, Clinic for Adults, Scientific-Practical Medical Center for Pediatric Cardiology and Cardiac Surgery, Kyiv, Ukraine
4- Department of Interventional Cardiology, Clinic for Adults, Scientific-Practical Medical Center for Pediatric Cardiology and Cardiac Surgery, Kyiv, Ukraine
5- Department of Pediatric Cardiology and Cardiac Surgery, Clinic for Adults, Scientific-Practical Medical Center for Pediatric Cardiology and Cardiac Surgery, Kyiv, Ukraine
Abstract (1304 Views)
Aims: Atrial fibrillation (AF) is one of the most common heart rhythm disorders. The study aimed to identify the effectiveness of surgical ablation of the atrial fibrillation substrate in cardiac surgery.
Materials & Methods: From January 1, 2016, to July 1, 2019, 46 procedures of left atrial surgical ablation of the atrial fibrillation substrate were performed in patients with paroxysmal, persistent, and long-lasting persistent AF based on the State Institution "Scientific and Practical Medical Centre of Pediatric Cardiology and Cardiac Surgery of the Ministry of Health of Ukraine". The control group consisted of 23 studied patients.
Findings: In most patients, recovery and retention of the sinus rhythm were observed throughout the entire time after the surgical intervention. 25 (56.8%) such patients were registered after three months, 30 (68.2%) after six months, 28 (63.6%) patients retained a sinus rhythm 12 months later and as a result of further observations. 7 (15.9%) patients have a persistent AF, 5 (11.4%) patients have a typical atrial flutter, 1 (2.2%) was diagnosed with a rhythm disorder in the form of left atrial flutter, 1 (2.2%) – with a persistent multi-focal atrial tachycardia. During the first 3-6 months after the procedure, some patients have recurrent AF. 15% of patients require restoration of the sinus rhythm by electro cardioversion and consultation of an arrhythmology-electrophysiologist to select antiarrhythmic therapy.
Conclusion: The rationality and effectiveness of surgical ablation of the atrial fibrillation substrate in cardiac surgery were determined.
Materials & Methods: From January 1, 2016, to July 1, 2019, 46 procedures of left atrial surgical ablation of the atrial fibrillation substrate were performed in patients with paroxysmal, persistent, and long-lasting persistent AF based on the State Institution "Scientific and Practical Medical Centre of Pediatric Cardiology and Cardiac Surgery of the Ministry of Health of Ukraine". The control group consisted of 23 studied patients.
Findings: In most patients, recovery and retention of the sinus rhythm were observed throughout the entire time after the surgical intervention. 25 (56.8%) such patients were registered after three months, 30 (68.2%) after six months, 28 (63.6%) patients retained a sinus rhythm 12 months later and as a result of further observations. 7 (15.9%) patients have a persistent AF, 5 (11.4%) patients have a typical atrial flutter, 1 (2.2%) was diagnosed with a rhythm disorder in the form of left atrial flutter, 1 (2.2%) – with a persistent multi-focal atrial tachycardia. During the first 3-6 months after the procedure, some patients have recurrent AF. 15% of patients require restoration of the sinus rhythm by electro cardioversion and consultation of an arrhythmology-electrophysiologist to select antiarrhythmic therapy.
Conclusion: The rationality and effectiveness of surgical ablation of the atrial fibrillation substrate in cardiac surgery were determined.
Keywords:
References
1. Santos JV, Pereira J, Pinto R, Castro PM, Azevedo E, Freitas A. Atrial fibrillation as an ischemic stroke clinical and economic burden modifier: A 15-year nationwide study. Value Health. 2017;20(8):1083-91. [Link] [DOI:10.1016/j.jval.2017.04.018] [PMID]
2. Brandes A, Smit MD, Nguyen BO, Rienstra M, Van Gelder IC. Risk factor management in atrial fibrillation. Arrhythm Electrophysiol Rev. 2018;7(2):118-27. [Link] [DOI:10.15420/aer.2018.18.2] [PMID] [PMCID]
3. Andrade J, Khairy P, Dobrev D, Nattel S. The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms. Circ Res. 2014;114(9):1453-68. [Link] [DOI:10.1161/CIRCRESAHA.114.303211] [PMID]
4. Allan V. Are cardiovascular risk factors also associated with the incidence of atrial fibrillation? A systematic review and field synopsis of 23 factors in 32 population-based cohorts of 20 million participants. Thromb Haemost. 2017;117(5):837-50. [Link] [DOI:10.1160/TH16-11-0825] [PMID] [PMCID]
5. Kochhäuser S, Dechering DG, Trought K, Hache P, Haig-Carter T, Khaykin Y, et al. Predictors for progression of atrial fibrillation in patients awaiting atrial fibrillation ablation. Can J Cardiol. 2016;32(11):1348-54. [Link] [DOI:10.1016/j.cjca.2016.02.031] [PMID]
6. Christophersen IE, Ellinor PT. Genetics of atrial fibrillation: from families to genomes. J Hum Genet. 2016;61(1):61-70. [Link] [DOI:10.1038/jhg.2015.44] [PMID]
7. Calkins H, Hindricks G, Cappato R, Kim YH, Saad EB, Aguinaga L, et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Heart Rhythm. 2017;14(10):e275-444. [Link]
8. Bunch TJ, May HT, Bair TL, Jacobs V, Crandall BG, Cutle M, et al. The impact of age on 5-year outcomes after atrial fibrillation catheter ablation. J Cardiovasc Electrophysiol. 2016;27(2):141-6. [Link] [DOI:10.1111/jce.12849] [PMID]
9. Metzner I. Ablation of atrial fibrillation in patients ≥75 years: long-term clinical outcome and safety. Europace. 2016;18(4):543-54. [Link] [DOI:10.1093/europace/euv229] [PMID]
10. Richter S, Di Biase L, Hindricks G. Atrial fibrillation ablation in heart failure. Eur Heart J. 2019;40(8):663-71. [Link] [DOI:10.1093/eurheartj/ehy778] [PMID]
11. Ganesan AN, Chew DP, Hartshorne T, Selvanayagam JB, Aylward PE, Sanders P, et al. The impact of atrial fibrillation type on the risk of thromboembolism, mortality, and bleeding: A systematic review and meta-analysis. Eur Heart J. 2016;37(20):1591-602. [Link] [DOI:10.1093/eurheartj/ehw007] [PMID]
12. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J. 2015;16(3):233-71. [Link] [DOI:10.1093/ehjci/jev014] [PMID]
13. Damiano Jr RJ, Schwartz FH, Bailey MS, Maniar HS, Munfakh NA, Moon MR, et al. The Cox maze IV procedure: Predictors of late recurrence. J Thorac Cardiovasc Surg. 2011;141(1):113-21. [Link] [DOI:10.1016/j.jtcvs.2010.08.067] [PMID] [PMCID]
14. Markowitz SM, Thomas G, Liu CF, Cheung JW, Ip JE, Lerman BB. Approach to catheter ablation of left atrial flutters. J Cardiovasc Electrophysiol. 2019;30(12):3057-67. [Link] [DOI:10.1111/jce.14209] [PMID]
15. Lee KW, Yang Y, Scheinman MM. Atrial flutter: A review of its history, mechanisms, clinical features and current therapy. Curr Probl Cardiol. 2005;30(3):12-67. [Link] [DOI:10.1016/j.cpcardiol.2004.07.001] [PMID]
16. Ramlawi B, Abu Saleh WK. Surgical ablation of atrial fibrillation. Methodist Debakey Cardiovasc J. 2015;11(2):104-8. [Link] [DOI:10.14797/mdcj-11-2-104] [PMID] [PMCID]
17. Ruaengsri C, Schill MR, Khiabani AJ, Schuessler RB, Melby SJ, Damiano Jr RJ. The Cox-maze IV procedure in its second decade: Still the gold standard?. Eur J Cardiothorac Surg. 2018;53(suppl 1):i19-25. [Link] [DOI:10.1093/ejcts/ezx326] [PMID] [PMCID]
18. Ad N, Holmes SD, Lamont D, Shuman DJ. Left-sided surgical ablation for patients with atrial fibrillation who are undergoing concomitant cardiac surgical procedures. Ann Thorac Surg. 2017;103(1):58-65. [Link] [DOI:10.1016/j.athoracsur.2016.05.093] [PMID]
19. Lawrance CP, Henn MC, Damiano Jr RJ. Surgery for atrial fibrillation. Cardiol Clin. 2014;32(4):563-71. [Link] [DOI:10.1016/j.ccl.2014.07.003] [PMID] [PMCID]
20. Ad N. The Cox-Maze procedure: history, results, and predictors for failure. J Interv Card Electrophysiol. 2007;20(3):65-71. [Link] [DOI:10.1007/s10840-007-9176-z] [PMID]
21. Gillinov AM. Ablation of atrial fibrillation with mitral valve surgery. Curr Opin Cardiol. 2005;20(2):107-14. [Link] [DOI:10.1097/01.hco.0000153554.48122.86] [PMID]
22. Kottkamp H, Bender R, Berg J. Catheter ablation of atrial fibrillation: how to modify the substrate?. J Am Coll Cardiol. 2015;65(2):196-206. [Link] [DOI:10.1016/j.jacc.2014.10.034] [PMID]
23. Wang X, Wang C, Ye M, Lin J, Jin J, Hu Q, et al. Left atrial concomitant surgical ablation for treatment of atrial fibrillation in cardiac surgery: A meta-analysis of randomized controlled trials. PLoS One. 2018;13(1):e0191354. [Link] [DOI:10.1371/journal.pone.0191354] [PMID] [PMCID]
24. Barra S, Narayanan K, Boveda S, Primo J, Gonçalves H, Baran J, et al. Atrial fibrillation ablation and reduction of stroke events: Understanding the paradoxical lack of evidence. Stroke. 2019;50(10):2970-6. [Link] [DOI:10.1161/STROKEAHA.119.026890] [PMID]
25. Mangiafico V, Saberwal B, Lavalle C, Raharja A, Ahmed Z, Papageorgiou N, et al. Impact of obesity on atrial fibrillation ablation. Arch Cardiovasc Dis. 2020;113(8-9):551-63. [Link] [DOI:10.1016/j.acvd.2020.03.023] [PMID]
26. Aldaas OM, Malladi CL, Hsu JC. Catheter ablation of atrial fibrillation in patients with heart failure. Am J Cardiol. 2019;123(1):187-95. [Link] [DOI:10.1016/j.amjcard.2018.09.013] [PMID]
27. Cheng EP, Liu CF, Yeo I, Markowitz SM, Thomas G, Ip JE, et al. risk of mortality following catheter ablation of atrial fibrillation. J Am Coll Cardiol. 2019;74(18):2254-64. [Link] [DOI:10.1016/j.jacc.2019.08.1036] [PMID]
28. Davoudi Kongsofla M, Najafi Ghezeljeh T, Saeidi A, Peyravi H, Kiaroosta N. Design and evaluation of a smartphone-based application to manage the treatment of people with heart failure. Iran J War Public Health. 2019;11(3):125-31. [Persian] [Link] [DOI:10.29252/ijwph.11.3.125]
29. Aghayousefi A, Amirpour B, Alipour A, Zare H. Effect of cognitive processing therapy on cardiovascular biomarkers of veterans with post-traumatic stress disorder. Iran J War Public Health. 2015;7(1):43-8. [Persian] [Link]